Self-Measurement and Self-Titration in Hypertension

Results: Overall, 80% of patients were satisfied (58%) or very satisfied (23%) with the program (95% confidence interval, 73% to 87%). Regarding compliance, 78% of patients fully complied with self-measurement, and just over 71% titrated their treatment adequately. Physicians were satisfied (52%) or very satisfied (22%) with the program. Between the first and final visits (at week 8), office systolic/diastolic BP (mean SD) decreased significantly from 151 9/91 6t o 143 13/84 11 mmHg. During the trial, HBPM (mean SD) decreased significantly from 149 13/86 12 to 138 16/81 10 mmHg. No significant safety issues were reported. Conclusions: This innovative approach to the management of hypertension, combining self-measurement and selftitration, is feasible, well-accepted by both patients and physicians, and safe. Am J Hypertens 2007;20:1314‐1320 © 2007 American Journal of Hypertension, Ltd.